tiprankstipranks

Charles Kummeth Insider Profile

4 Followers
Charles Kummeth, CEO, Director at Bio-Techne, holds 38.50K shares in Orthofix (Ticker: OFIX), holds 16.57K shares in Gentherm (Ticker: THRM), holds 1.28M shares in Bio-Techne (Ticker: TECH).
tipranks
Charles Kummeth

Charles Kummeth
Bio-Techne (TECH)
CEO, Director

Ranked #31,146 out of 98,042 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+7.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$98M
98.55%
0.85%
0.61%
0.00%
A breakdown of Charles Kummeth's holdings

Insider Roles

Bio-Techne
(TECH)
CEO, Director
Gentherm
(THRM)
Director
Orthofix
(OFIX)
Director
Quantum-Si
(QSI)
Director
Roles that Charles Kummeth holds in companies

Most Profitable Insider Trade

Stock:
Bio-Techne
(TECH)
Rating:Informative Buy
Date:Sep 11, 2019 - Sep 11, 2020
Return:+25.20%
The most profitable trade made by Charles Kummeth

Charles Kummeth's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Bio-Techne
Aug 17, 2023
CEO, Director
Uninformative Buy
757.85K
$96.52M
Gentherm
May 20, 2024
Director
Uninformative Buy
$829.49K
Orthofix
Jun 20, 2024
Director
Uninformative Buy
195.01K
$595.24K
Quantum-Si
Director
SPA
Sparton Corp
Mar 04, 2019
Uninformative Sell
299.64K
$0.00
List of latest transactions for each holding click on a transaction to see Charles Kummeth's performance on stock

Charles Kummeth insider profile FAQ

What is the percentage of profitable transactions made by Charles Kummeth?
The percentage of profitable transactions made by Charles Kummeth is 75%.
    What is the average return per transaction made by Charles Kummeth?
    The average return per transaction made by Charles Kummeth is 7.30%.
      What stocks does Charles Kummeth hold?
      Charles Kummeth holds: TECH, THRM, OFIX, QSI, SPA stocks.
        What was Charles Kummeth’s latest transaction?
        Charles Kummeth latest transaction was an Uninformative Buy of $195.01K.
          What was Charles Kummeth's most profitable transaction?
          Charles Kummeth’s most profitable transaction was an Informative Buy of TECH stock on September 11, 2019. The return on the trade was 25.20%.
            What is Charles Kummeth's role in Bio-Techne?
            Charles Kummeth's role in Bio-Techne is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.